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The William H. Beaumont Medical Research Honor Society is an honorary 
research society of medical students that was established in 1935 to 
honor Dr. William H. Beaumont, a pioneer in physiology research. The 
organization seeks to foster a continuing interest in biomedical research 
and to promote its value in the practice of medicine. As a part of this 
mission, the Society integrates current research topics in the curriculum; 
develops a research journal showcasing GW student research; makes 
available information on research opportunities and seminars throughout 
the area, including the William T. Gill Summer Fellowship for GW medical 
students; and highlights student and faculty research accomplishments at 
the annual GW Research Day.
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The George Washington University School of 
Medicine and Health Sciences (SMHS) is pleased 
to invite you to read the third edition of Fusion. 
Our 2009 edition showcases a spectrum of stu-
dent research projects, including basic science 
research, clinical research, health policy, and 
research abroad. Leading faculty members at The 
George Washington University Medical Center 
have mentored the majority of the journal’s stu-
dent authors, from endeavors in a hookworm vac-
cine clinical trial in Brazil, to exploring cardiac 
pathophysiology, to spinal surgery at GW. 
This year, we invited physicians’ assistant 
students, medical students, and physical therapy 
students to submit their research. All 18 research 
projects presented in this issue were completed 
while students attended SMHS. Student officers 
of The William H. Beaumont Medical Research 
Honors Society were responsible for the editing 
and production of this year’s journal. The edito-
rial board included members from the medical 
school classes of 2011 and 2012. 
We also have an exciting new addition to the 
Beaumont Society’s activities — a Journal Club. 
This year, we initiated monthly meetings to 
create an arena for students to discuss landmark 
research studies. These meetings are led by one of 
two members of the Beaumont Society and are 
moderated by faculty members including Dean 
James L. Scott, MD, FACEP; Dean W. Scott 
Schroth, MD, MPH; and Anne Hirshfield, PhD, 
our faculty advisor in the Office of Research. 
Journal Club meetings allow students to better 
understand the clinical relevance of scientific 
research and provide them with the opportunity 
to critically evaluate the strengths and weaknesses 
of various studies. We especially would like to 
acknowledge Sarah Brown, Journal Club director, 
for her exceptional job launching the Journal 
Club. We hope that Journal Club will continue 
to be an active and integral part of the Beaumont 
Society. 
The Office of Student Opportunities, led by 
Cynthia Powell and Nancy Campbell, has been 
paramount in introducing students to research 
projects throughout the United States as well 
as internationally. One such opportunity, the 
William T. Gill Summer Fellowship, funded 
the basic science and clinical research projects 
of many students featured in this year’s journal. 
The Dean’s Office and the Office of Student 
Opportunities also have created the research track 
program, which helps students direct their career 
toward academic medicine. 
We are most grateful for the continual 
encouragement and support of Dean Scott, Dean 
Schroth, and Assoc. Vice President Hirshfield 
whose guidance helped shape the mission of the 
Beaumont Society, as well as the many dedicated 
faculty members at GW who mentored our peers. 
In particular, we would like to thank Thomas 
Kohout, in Medical Center Communications 
and Marketing, for his creativity, diligence, and 
enthusiasm in assembling this journal. Finally, we 
also thank our editorial board for its hard work. 
Again, we invite you to share our enthusiasm 
for student research, and encourage our peers to 
continue careers in academic medicine to advance 
patient care in all dimensions, whether in basic 
science knowledge, clinical care, or health policy. 
Enjoy Fusion 2009.
Talya Bordin-Wosk, MS II 
Amrita Karve, MS II 
Talya Bordin-Wosk, Msii
aMriTa karve, Msii
 from the editors. . .
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New endeavors, like break-
through research, are inherently 
exciting. However, most of the 
time, those moments come after 
years of struggle by many dedi-
cated individuals. Fusion, now 
in its third edition, came from 
dedicated work by a number of 
people as well. It is my pleasure 
to recognize just a few of those 
who dedicated their time and 
effort to bring this magazine to 
you. 
This journal was conceived 
by medical students in the 
William H. Beaumont Medical 
Research Honor Society and 
I commend them for their 
work. Specifically, I want to recognize Talya 
Bordin-Wosk and Amrita Karve for their cre-
ativity and thoroughness in gathering, editing, 
and organizing these projects, and Thomas 
Kohout for serving as the managing editor. This 
journal would not exist without their hard work 
and vision. I also want to thank Associate Vice 
President for Health Research Anne Hirshfield, 
PhD, for her guidance and mentorship of the 
Beaumont Society and her encouragement of the 
students working on this journal. We also are 
indebted to the Office of Student Opportunities 
which arranged many of these projects for the 
students, and the generous supporters of that 
office. In addition, none of this would have been 
possible without the active involvement of so 
many of our faculty in the research and other 
activities of our medical students. To all of you, a 
collective thank you.
I take great pride in the scientific endeavors 
of our students, residents, faculty, and staff. I was 
especially delighted to read about their activities 
and accomplishments through the experiences 
in the pages of Fusion. I hope you share in that 
delight as you read on.
James L. Scott, MD 
Dean, School of Medicine and Health Sciences, 
Professor of Emergency Medicine
 from the dean’s office. . .
Fusion • 2009 5
On behalf of the students of GW’s William H. 
Beaumont Medical Research Honor Society, 
I welcome you to peruse the 2009 edition of 
Fusion, the third volume of a publication created 
by the members of this prestigious honor society. 
The Beaumont Society was established at the 
GW School of Medicine in 1935 to promote 
student research. 
You will see from the following pages the 
depth of research experiences from our brightest 
students, not only on a local level but globally 
as well. The commitment to the mission of 
healing and discovery is evidenced in the work 
showcased throughout this publication. These 
students bring their excitement and passion 
for learning to you in a way that represents 
the opportunities for medical advancement in 
various fields. Thus, our citizens will reap the 
benefits of their labor in the years ahead.
Fusion is an entirely student run publication 
which further highlights the students’ abilities as 
promising doctors and researchers. In addition, 
we salute the faculty advisors and all those 
who have mentored and assisted in any way to 
make this publication a reality. We also need 
to acknowledge the William T. Gill Summer 
Fellowship, which on a yearly 
basis, provides stipends to 
eligible students to gain 
valuable experience in research 
during the summer months. 
Wherever their careers 
take them we know that the 
students of the Beaumont 
Society will make their 
mark in the medical field 
throughout the nation and 
world. I am honored to serve 
as the Society’s faculty advisor 
and am happy to support 
these gifted students in their 
research endeavors.
Anne N. Hirshfield, PhD 
Associate Vice President for Health Research, 
Compliance, and Technology Transfer
 from the research office. . .
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Identifying the Cause of ectopic beats  
during the Initiation of Cardiac arrhythmias 
Craig ForleiTer, Msii 
Research Track 
Advisor: Narine Sarvazyan, 
PhD, associate professor, 
Department of Pharmacology 
and Physiology, 
The George Washington 
University School of Medicine 
and Health Sciences.
Heart disease and its associated 
complications take the lives of 
more than 700,000 Americans 
each year, making it the leading 
cause of death in this country. It 
has long been understood that 
time is of the essence when an 
individual is in the midst of a 
myocardial infarction (MI), as the 
cardiomyocytes have only hours to 
survive without adequate oxygen-
ation and lack the ability to regen-
erate once they begin to necrose. 
Therefore, current standards of 
care in cardiac catheterization 
have focused on rapid dissolu-
tion of coronary obstructions and 
restoration of blood flow to the 
myocardium using a variety of 
percutaneous coronary interventions (PCI).1 
Directly related to this is a well-studied 
phenomenon known as “ischemic-reperfusion 
injury.” Simply put, it is not only the deprivation 
of oxygen that leads to catastrophic metabolic 
and ionic changes within the myocytes, but also 
the restoration of blood flow which adds further 
insult to the already damaged cells. Even in 
patients who survive an MI, this phenomenon 
increases the risk of life-threatening sustained 
arrhythmias and must be carefully monitored. 
At The George Washington University 
Medical Center, the cardiac research labora-
tory of Matthew Kay, DSBME, and Narine 
Sarvazyan, PhD, has developed a novel rat heart 
model of cardiac ischemia and reperfusion. With 
the model, coronary flow is carefully controlled 
to closely mimic in vivo MI conditions. The 
hearts of anesthetized rats are explanted and ret-
rograde perfused through the aorta with an oxy-
genated nutrient solution that supports the organ 
for several hours. The Left Anterior Descending 
(LAD) artery is delicately dissected and micro-
cannulated with a polyimide tube (Figures 1a 
and 1b). In this way, the flow of solution to the 
vascular bed supplied by the LAD is intricately 
controlled.2 
The instrumentation is a custom arrange-
ment designed to visualize electrophysiological 
signals, monitor flow, and record EKG signals, 
while keeping the heart viable (Furure 1c. A dual 
CCD camera system enabled us to collect near 
simultaneous data describing the metabolic and 
electrical conditions of the heart. We observed 
the geometry and degree of ischemia by imaging 
the fluorescence of NADH, which accumulates 
in the mitochondria of ischemic myocytes. After 
staining the heart with a potentiometric probe, 
transmembrane potentials were imaged with the 
second camera to reveal the progression of action 
potentials throughout the epicardial surface of 
the heart. At the end of the studies, imaging data 
were processed using custom algorithms. We then 
examined each data frame in detail to identify the 
electrophysiological origins of ectopic beats and 
any arrhythmogenic conditions (Figure 1d).3
By subjecting hearts to repeated phases of 
local ischemia, low-flow and full-flow reperfusion, 
we sought to support the working hypothesis that 
eCTopIC beaTs Continued on p. 7
Figure 1a:
Figure 1d:
Figure 1c:
Figure 1b:
 basic science. . .
fIgure 1: 1a and 1b: 
The LAD is delicately dissected 
and microcannulated with a 
polyimide tube, held in place 
with two sutures. Figure 1c: 
Custom arrangement designed 
to visualize electrophysiological 
signals, monitor flow, and 
record EKG signals, while 
keeping the heart viable. 
Figure 1d (images 1–4): 
Transmembrane potentials were 
imaged with the second camera 
to reveal the progression of 
action potentials throughout 
the epicardial surface of the 
heart. Figure 1d (image five): 
Low-flow reperfusion yields a 
very heterogeneous metabolic 
substrate that is prone to 
increased incidence of sustained 
arrhythmias.
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low-flow reperfusion yields a very heterogeneous 
metabolic substrate that is prone to increased 
incidence of sustained arrhythmias (Figure D, last 
image). If proven, one can begin to extrapolate 
this hypothesis to a clinical setting: if heightened 
excitability of certain myocytes during reperfu-
sion is significantly arrhythmogenic, then perhaps 
catherization lab, emergency room, and even CPR 
protocols should be amended to consider elevated 
myocyte excitability resulting from reperfusion in 
addition to the complete restoration of blood flow 
to ischemic myocardium. 
As the data continue to be analyzed, the lab 
is already performing experiments to comple-
ment the work that has been accomplished. We 
are studying a phenomenon known as “cardiac 
eCTopIC beaTs Continued from p. 6 steal,” and delving deeper into the origins of 
ectopic beats by studying how Purkinje fibers may 
participate in their formation. As the only lab in 
the world that uses a model and instrumentation 
such as this, the lab aims to continue refining its 
hypotheses and striving to investigate the prob-
lems that will bring clinically applicable science 
from the bench-top to the bedside. 
reFerences: 
1. dave rM. Changing the Standard of Care in STEMI 
PCI. Cath Lab Digest. 2008; 16(9): 1,8–13.
2. sWiFT l, MarTell B, khaTri v, aruTunyan a, sarvazyan n, kay M. 
Controlled regional hypoperfusion in Langendorff 
heart preparations. Physiol Meas. 2008; 29(2):269–79.
3. kay MW, sWiFT lM, MarTell B, aruTunyan a, sarvazyan n. Loca-
tions of ectopic beats coincide with spatial gradients 
of NADH in a regional model of low-flow reperfu-
sion. Am J Physiol Heart Circ Physiol. 2008; 294(5): 
H2400-5.
According to a survey performed by the National 
Center for Cancer and Complementary Medicine 
(NCCM) in 2004, 62 percent of adults in the 
United States use some form of Complementary 
and Alternative Medicine (CAM). Excluding 
prayer used specifically for health, biologically-
based therapies are the most popular CAM 
method used (22 percent).1 Biologically-based 
therapies include supplements, which may con-
tain ingredients such as botanicals, vitamins, 
minerals, etc., and are used for a variety of rea-
sons, ranging from overall health maintenance 
to disease treatment. However, the full extent of 
the effectiveness and safety of most supplements 
is unknown, making them potentially harmful 
to consumers. The necessity for public knowledge 
has resulted in an increasing amount of research 
focused on studying the mechanisms and effects 
of botanicals. The purpose of my research was to 
study the effects of a botanical product, Moringa 
oleifera, on prostate cancer. M. oleifera, also 
known as “the Miracle Tree,” is a pan-tropical 
tree that is used throughout the world in over 
300 commercial and medicinal uses, including 
water purification and treatments for malnutri-
tion, hypertension, inflammation, diabetes and 
cancer.2 However, the mechanisms underlying its 
effects in prostate cancer are not known. 
The miracle Tree: studying the effects  
of moringa oleifera in prostate Cancer
ChrisTine lin, Msii 
Integrative Medicine Track 
Advisor: Julia T. Arnold, PhD 
National Center for Cancer and 
Alternative Medicine, Endocrine 
Section; National Institutes of 
Health, Bethesda, Md.
To mimic the microenvironment of human 
prostate cancer, prostate epithelial cancer cells 
were grown together with prostate stromal cells 
but separated by a basement membrane-like film 
that allowed for the passage of stromal media-
tors to epithelial cells. One significant stromal 
mediator is TGFβ1, which plays a role in cancer 
progression by inducing a reactive stroma that 
increases cell proliferation. TGFβ1 overproduc-
tion in the prostate is associated with increased 
tumor grade and the presence of metastases. An 
important hormonal mediator is dehydroepi-
androsterone (DHEA), which has been shown 
to increase gene expression of prostate-specific-
antigen (PSA — clinically used as a marker for 
prostate cancer) in this TGFβ1-induced reactive 
stromal environment.3 The co-cultures of prostate 
epithelial and stromal cells were treated with 
TGFβ1 and DHEA. They were then treated 
with either ethanol or aqueous M. oleifera leaf 
extracts with the hypothesis that M. oleifera 
would reverse DHEA-induced PSA gene expres-
sion. The levels of PSA gene expression were 
quantified using RealTime RTPCR. 
Combined results from five separate experi-
ments found that, compared to controls treated 
mIraCle Tree Continued on p. 8
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with only DHEA and TGFβ1, addition of 
aqueous extract of M. oleifera to DHEA and 
TGFβ1 increased PSA gene expression in epithe-
lial cells, while ethanol extract of M. oleifera to 
DHEA and TGFβ1 decreased PSA gene expres-
sion. These results suggest that ethanol and 
aqueous M. oleifera extracts contained different 
compounds that interacted with each other (by 
unknown mechanisms) to result in contrasting 
effects. This contrast between different extrac-
tions of M. oleifera demonstrates the major 
challenge in studying phytomedicines. Botanicals 
are complex mixtures of variable composition 
and unknown active compounds. Protocols for 
standardizing extract components to achieve 
reproducible results are still being developed. 
mIraCle Tree Continued from p. 7 Nevertheless, the preliminary results of this 
research suggest that M. oleifera may have an 
effect on PSA gene expression in the prostate. 
However, more research is needed to determine 
whether M. oleifera is beneficial or detrimental 
in treating prostate cancer.
reFerences
1. naTional CenTer For CanCer and CoMpleMenTary MediCine. 
The Use of Complementary and Alternative Medi-
cine in the United States, 2007; Retrieved Oct. 7, 
2008, from nccam.nih.gov/news/camsurvey_fs1.htm.
2. anWar F, laTiF s, ashraF M, gilani ah. “Moringa oleifera: A 
Food Plant with Multiple Medicinal Uses.” Phyto-
therapy Research. 2006; 21(1): 17–25.
3. gray ne, liu X, Choi r, BlaCkMan Mr, arnold JT. Endocrine-
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neha JakheTe, Msi 
Research Track 
Advisor: Bibiana Bielekova, MD 
National Institute of Neurological 
Diseases and Stroke, 
National Institutes of Health, 
Bethesda, Md.
Multiple Sclerosis (MS) is an inflammatory dis-
ease of the central nervous system characterized 
by lesions in the brain and spinal cord. Although 
there is no doubt that the disease is immune-
mediated, the immune cells that are pathogenic 
and the antigen being targeted are unknown.1 
Daclizumab therapy is one of many experi-
mental therapies in MS currently being studied. 
The drug contains an antibody against the CD25 
subunit of the IL-2 receptor (IL-2R). IL-2 is an 
important T cell growth factor that promotes T 
cell proliferation and differentiation.2 Blocking 
CD25 significantly decreases the binding affinity 
of IL-2, shutting down the IL-2 signaling path-
ways of T cells.3 
Only a small proportion of resting T cells 
express CD25 and have functioning high affinity 
IL-2R. The majority of these are FoxP3+ T 
regulatory cells (T-regs). T-regs are dependent on 
IL-2 for their in vivo proliferation and survival.4 
Therefore, one can hypothesize that blocking 
CD25 with Daclizumab, which leads to dimin-
ished consumption of IL-2 by T cells, may result 
in decreased in vivo proliferation of T-regs and/or 
their diminished survival. The question of T-reg 
dependency on IL-2 was addressed previously in 
mice, where it was shown that in the absence of 
IL-2, T-regs can use other cytokines, such as IL-7, 
to partially compensate for the lack of survival 
signal.4 However, this question was never exam-
ined in humans. Consequently we wanted to 
assess numbers and in vivo proliferation of T-regs 
before and during Daclizumab therapy. 
Cryopreserved peripheral blood mononuclear 
cells (PBMCs) from 26 MS patients from two 
separate clinical trials were used for an evalua-
tion of surface molecules (CD3, CD4, CD8) and 
intracellular cytokine stain for FoxP3 and Ki67. 
FoxP3 is a T-reg marker and Ki67 is a prolifera-
tion marker, both of which bind to the chromatin 
in the cell nucleus.2 Three separate time points 
were taken to examine the time course effects of 
Daclizumab treatment. We included evaluation of 
CD127 expression, a sub unit of the IL-7 receptor, 
to examine if T cells upregulate CD127 to com-
pensate for the blocked CD25 and inability to 
utilize IL-2. Stained PBMCs were analyzed using 
the flow cytometer.
Results showed that while T-reg cell numbers 
decreased 8.1 percent (p < 0.05), Daclizumab had 
no significant effect on their in vivo proliferation. 
We did observe that of the proliferating T-reg 
cells, there was a 46 percent increase in CD127 
expression following treatment with Daclizumab 
(p < 0.05). 
Because CD25 on T-reg cells is blocked by 
Daclizumab, the cells are unable to utilize IL-2 
The effect of Daclizumab on foxp3+ T regulatory  
Cells in multiple sclerosis
DaClIzumab Continued on p. 9
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Choroidal neo-
vascularization 
(CNV) is a patho-
logical process in 
which new blood 
vessels grow from 
preexisting vessels 
in the choroid 
through Bruch’s 
membrane and 
invade the nor-
mally avascular 
subretinal space. 
These newly 
formed vessels con-
tribute to the accu-
mulation of blood 
in the subretinal 
space, a condition 
that leads to pho-
toreceptor degen-
eration and death.1 
The formation of 
CNV complexes 
is the hallmark 
of exudative age-
related macular 
degeneration 
(AMD).2 Remodeling of the extracellular matrix 
plays a key role in neovascularization during 
migration and tubule formation of endothelial 
cells.3 The delicate balance between matrix 
(necessary for survival) and subsequently upregu-
late CD127 expression in an attempt to compen-
sate for the blocked CD25. These findings indi-
cate that human T-regs, like their animal coun-
terparts, may be able to utilize another cytokine 
for growth and survival in the absence of IL-2. 
Despite the fact that Daclizumab mildly inhibits 
T-reg numbers in vivo, its overall effect on brain 
inflammation in MS is inhibitory.5 This sug-
gests that either FoxP3+ T-regs are not crucially 
important for MS disease process, or despite their 
lower numbers, their function is not significantly 
inhibited by Daclizumab. These conclusions will 
be tested in the future studies.
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Doxycycline-mediated Inhibition of Choroidal neovascularization
metalloproteinases (MMPs), such as MMP-2 
and MMP-9, and their inhibitors plays an 
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fIgure 1: Effects of doxycycline on experimental CNV in rats. Rats were fed doxycycline enhanced 
water for seven days and then laser injury was performed to induce CNV. Seven days post-laser, animals 
were euthanized and endothelial cells were labeled with isolectin-IB4 in RPE/choroid flatmounts. Panel A 
shows representative images of isolectin-IB4 vessel staining (blue) in laser lesions from animals treated 
with the indicated doses of doxycycline. Panel B shows a graphical plot of the quantification of CNV lesion 
volumes of doxycycline-treated rats. Each point in this graph represents the average of three volume 
measurements per lesion. Five animals per condition were analyzed, and n represents the number of lesions. 
The median values are depicted in blue. 
DoxyCyClIne Continued on p. 10
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important role in this remodeling.4 Doxycycline 
is a broad spectrum antibiotic that has anti-
angiogenic properties and inhibitory activity 
against MMPs.5 We investigated the effect of 
doxycycline on CNV, on regulation of MMP-2 
and MMP-9 and on control of anti-angiogenic 
pigment epithelium-derived factor (PEDF). 
Doxycycline was orally administered to rats 
at 500, 50, 5, and 0.5 mg/kg/day, using non-
treated animals as controls. After seven days 
of treatment, experimental CNV was induced 
using a ND:YAG 532-nm laser (Alcon). Seven 
days post-induction, animals were euthanized, 
and eyes enucleated. RPE/choroid flat-mounts 
were labeled with isolectin IB4 to determine 
CNV volumes using confocal microscopy and 
VolocityTM software.6 Plasma protein levels of 
MMP-2, MMP-9, and PEDF were determined by 
ELISA. MMP catalytic activity was determined 
in solution using fluorogenic gelatin and peptide 
substrates, by gelatin zymography in SDS-PAGE 
and by in situ DQ-gelatin zymography in RPE/
choroid sections. 
Our results demonstrated that CNV volumes 
decreased logarithmically with doxycycline treat-
ment. A dosage of 500 mg/kg/day caused a 70 
percent (p<0.0005) inhibition of CNV compared 
to control animals (Figure 1). Doxycycline ele-
vated PEDF levels in plasma, but did not affect 
the plasma pro- and active MMP-2 and MMP-9 
levels. However, doxycycline inhibited the 
DoxyCyClIne Continued from p. 9 enzymatic activity of the purified MMP-2 and 
MMP-9 enzymes and the in situ gelatinolytic 
activities in RPE/choroid sections. 
We concluded that doxycycline inhibited the 
progression of experimental CNV, elevated the 
plasma PEDF protein levels and inhibited the 
catalytic activity of MMP-2 and MMP-9 without 
affecting their protein levels. These results sug-
gest a potential therapeutic role for doxycycline 
as an anti-angiogenic agent. 
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The functional link between mitochondrial 
biogenesis and neuronal Differentiation: Clinical 
Implications for mitochondrial encephalopathies
Mitochondrial encephalopathies are diseases 
caused by mitochondrial dysfunction due to 
impaired oxidative phosphorylation, resulting 
in decreased energy production in the form of 
ATP.1 The brain, a highly energy-dependent 
organ, is especially vulnerable to the effects of 
the mitochondrial dysfunction in mitochon-
drial encephalopathies.2 Mitochondrial diseases 
are especially challenging due to their diverse 
spectrum of manifestations and severity of the 
symptoms. It is also difficult to identify genetic 
mutations in mitochondrial or nuclear DNA. 
Clear basic pathogenetic mechanisms underlying 
mitochondrial diseases, as mitochondrial dys-
function gives rise to pleiotropic effects.3,4
As little is known about the functional 
link between mitochondrial biogenesis and 
neuronal differentiation, our study focused on 
the transcriptional regulation of mitochondrial 
biogenesis during the early steps of neurogenesis, 
more specifically during the transition from 
progenitors to differentiating neurons. We used 
the cellular paradigm PC12-ND6, a stable cell 
line engineered by Anne Chiaramello, PhD, 
Department of Anatomy and Regenerative 
Biology, The George Washington University 
School of Medicine and Health Sciences over-
expressing the neurogenic transcription factor 
NeuroD6 (ND6), which is critical for the neu-
ronal differentiation of progenitor cells during 
corticogenesis. It previously has been shown by 
Dr. Chiaramello’s laboratory that NeuroD6 is, 
by itself, sufficient to promote spontaneous dif-
ferentiation and neuronal survival.5 Genomic 
studies revealed that NeuroD6 induces the 
expression of several mitochondrial genes impli-
cated in oxidative phosphorylation and mito-
chondrial integrity.6
We investigated the functional link between 
NeuroD6 and the NDUFS4 subunit of the mito-
chondrial complex I, since our genomic studies 
showed increased expression NDUFS4 upon 
NeuroD6 expression. Furthermore, mutations in 
the NDUFS4 gene are frequently associated with 
mitochondrial encepalopathies.7 
Our results provide the first demonstration 
that mitochondrial biogenesis occurs during 
the very early stages of neuronal differentiation, 
at the lamellipodia stage preceding axonal and 
dendritic outgrowth and development. Our 
results also revealed that NeuroD6 is able to 
induce mitochondrial biogenesis in a manner 
similar to NGF. Finally, we found that NDUFS4 
expression levels increased concomitantly with 
NeuroD6-induced mitochondrial biogenesis. 
Thus, this work suggested that NeuroD6 may 
be a potential novel target for mutations associ-
ated with mitochondrial encephalopathies. 
Collectively, these results may provide molecular 
clues regarding the neuro-pathology associated 
with mitochondrial encephalopathies. 
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How does a 
healthy, normally 
functioning cell 
become malignant? 
The regulation of 
cell death con-
stitutes a critical 
response after 
carcinogenic geno-
toxin exposure.1,2 It 
is believed that cell 
cycle arrest allows 
sufficient time for 
surveillance of 
damaged DNA, 
subsequent repair, 
and/or activation 
of apoptotic path-
ways. However, 
many of the early 
transforming events that occur in carcinogen-
esis are only now becoming better understood. 
Signaling pathways that regulate apoptosis are 
altered in the process of carcinogenesis, resulting 
in enhanced cell survival. Notably, cellular death 
resistance is thought to be at the foundation of 
neoplastic evolution. I learned many aspects of 
cellular death resistance and its potential relation-
ship to the early stages of carcinogenesis while 
working in the laboratory of Susan Ceryak, PhD, 
MBA, associate research professor, Department 
of Pharmacology and Physiology, The George 
Washington University School of Medicine 
and Health Sciences. Her laboratory employs a 
clonal population of human fibroblasts that have 
survived genotoxin exposure and have acquired 
a general resistance to genotoxin-induced clono-
genic lethality.3,4 These cells have gained selective 
growth advantages that are characteristic of 
neoplastic cells, resulting in a survival pheno-
type. The goal of the laboratory is to identify the 
molecular mechanisms underlying this acquired 
resistance to genotoxin-induced cell death. 
I tested the hypothesis that cellular death 
resistance following carcinogen exposure is 
associated with altered DNA repair. I analyzed 
DNA damage after genotoxin exposure in death-
resistant and death-sensitive cells by using the 
enhanced Dna repair and Cellular Death resistance: 
a model for early events in Carcinogenesis
“Comet” assay, a technique that measures DNA 
strand breaks.5 The respective cell lines were 
exposed to a genotoxin (hydrogen peroxide), fol-
lowing which the cells were immersed in agarose 
on a glass slide, the nuclei were selectively lysed, 
and the cells were electrophoresed. During elec-
trophoresis, broken DNA pieces migrated out of 
the nucleus, forming “comets,” which were visual-
ized with a fluorescent stain. Our experimental 
conditions specifically allowed for the detection 
of double-stranded DNA breaks, which are lethal 
if unrepaired. 
In a series of experiments, 100 mM hydrogen 
peroxide exposure for 30 minutes caused exten-
sive DNA strand breaks in both death-resistant 
and death-sensitive cells compared to the 
untreated control (Figure 1). However, when the 
cells were allowed to recover for three hours after 
removal of the hydrogen peroxide, the death-
resistant cells showed markedly reduced DNA 
strand breaks, compared to the death-sensitive 
cells (Figure 2). These results suggest that the 
death-resistant cells undergo greater or faster 
DNA repair than the death-sensitive cells, which 
could be a key determinant of cellular death resis-
tance. Current studies continue to investigate and 
fIgure 1: 
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fIgure 1: H2O2-induced 
comet tail formation in death-
sensitive and death-resistant 
fibroblasts. Cells were incubated 
with 100 mM H2O2 for 30 min, 
and the cells were harvested 
and the cell membrane was 
permeabilized. The cells 
were then embedded in LM 
agarose on CometSlides and 
electrophoresis was carried 
out at 20 V for 30 min. The 
slides were then stained 
with SyBr Green to visualize 
cellular DNA and viewed with 
an OlympusIx70 fluorescent 
microscope.
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confirm these preliminary data. Future studies 
will determine whether the enhanced DNA repair 
capacity following genotoxin exposure will lead to 
genomic instability in these death-resistant cells. 
The results from these present and future studies 
will have a substantial impact on our under-
standing of carcinogenesis and early oncogenesis 
as well as significant clinical implications related 
to experimental therapeutics.
I would like to acknowledge and thank 
Dr. Ceryak and Kristen Wright for their time and 
guidance throughout the summer, as well as the 
entire laboratory staff.
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 DeaTh-sensITIVe DeaTh-resIsTanT fIgure 2: Death-resistant 
cells repair DNA strand breaks 
faster than death-sensitive cells. 
Cells were incubated with 100 
mM H2O2 for 30 min, at which 
time the cells were washed with 
PBS, the medium was replaced, 
and the cells were allowed to 
recover in the absence of H2O2 
for three additional hours. 
At this time, the cells were 
harvested and DNA damage 
was assessed by Comet assay, 
as described in the legend of 
Figure 1.
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Osteonecrosis, or avascular necrosis (AVN), is 
the interruption of blood supply to cortical bone 
leading to ischemia, bone death, and the collapse 
of weight-bearing joints. The development of 
osteonecrosis in the pediatric and adolescent 
population is uncommon, but the destructive 
pathology of the condition necessitates a 
thorough evaluation of the best treatment 
options in this population. The vascular anatomy 
of the hip makes the femoral head particularly 
vulnerable to AVN following interruption 
of its blood flow through fractures of the 
femoral head and neck, slipped capital femoral 
epiphyses, developmental dysplasia of the hip, 
and in Legg-Calve-Perthes Disease, among a 
variety of other conditions.1 In the pediatric 
and adolescent population, poor treatment 
outcomes have devastating implications with 
AVN accounting for 12 percent of all yearly hip 
replacements (including adult hip replacements). 
The treatment consensus in the current 
literature focuses on preserving an anatomic 
relationship between the femoral head and the 
acetabulum, with the explicit goal of avoiding 
hip replacement in the pediatric and adolescent 
population. 
The most effective treatment method for 
AVN in the pediatric population has long been 
debated. Research has proven non-operative 
interventions such as bracing ineffective.2 
Surgical procedures including distraction 
arthroplasty, varus, and Salter osteotomies have 
been proven effective at delaying hip replacement 
by shifting weight bearing to the healthy portion 
of the femoral head.3,4 The current literature lacks 
femoral Valgus With or Without salter osteotomy is effective 
for advanced femoral head osteonecrosis in pediatric patients
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a truly comprehensive examination of the use 
of a valgus osteotomy to treat osteonecrosis of 
the femoral head in the pediatric and adolescent 
population. To explore the efficacy of a valgus 
osteotomy in treating AVN in the pediatric 
population, we conducted a retrospective study 
of 19 children treated with valgus with or 
without Salter osteotomies for advanced femoral 
head osteonecrosis.
In our cohort, the average age at time of 
surgery was 9.8 years with an average of 37.5 
months of follow-up. Ten children underwent 
a valgus osteotomy while the remaining nine 
received a combination valgus and Salter 
osteotomy. In order to obtain quantifiable 
outcome measures, subjective determination 
of the children’s pain and activity limitation 
was determined from 
chart review. Objective 
classification of the 
children’s pre- and post-
operative X-rays was 
performed. Goniometric 
measurements of flexion, 
abduction, adduction, 
internal, and external rotation were also obtained 
from the charts.
For many of the children in the study, 
the most telling subjective measure of their 
improvement following the valgus osteotomy was 
the significant decrease in pain related by the 
child. This decrease is best illustrated by the 10 
cases in which pre-operative pain was moderate/
severe and improved to mild/none following 
surgical correction. Similar findings were noted 
in activity limitation where seven children 
reported severe activity limitation pre-operatively 
and no limitation post-operatively. Significant 
improvement in abduction and external rotation 
was also observed. 
The results of this study suggest that 
proximal femoral valgus osteotomy is an effective 
femoral Valgus Continued on p. 15
The current literature lacks a truly comprehensive examination of the use of 
a valgus osteotomy to treat osteonecrosis of the femoral head in the pediatric 
and adolescent population.
 clinical practice. . .
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treatment method for osteonecrosis of the 
femoral head in the pediatric population. This 
study is not a definitive statement on the efficacy 
of valgus osteotomy for avascular necrosis of 
the femoral head in children and adolescents. It 
is, however, a building block for future studies 
that can be aimed at determining the precise 
indications and contraindications for the 
procedure as well as better defining the device 
durability. 
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Anatomic location and bone 
quality are some factors that 
determine the complexity of 
fracture patterns. Proximal 
and distal humeral fractures 
and nonunions are examples 
of challenging injuries where 
the complex peri-articular 
anatomy, small fragment 
size of the short bony seg-
ments involved, and the 
osteopenic quality of the 
metaphyseal bone make 
stable fixation difficult.1,2,3 
Due to these anatomical dif-
ficulties, treating surgeons 
have sometimes been obliged 
to choose between treating 
fractures of the proximal 
and distal one-third of the 
humeral shaft with a smaller, 
“weaker” plate that allows 
more screws to be placed in 
the fracture segments, or a 
plate of larger diameter and 
greater implant strength with 
fewer screws in the short bony 
segments. Innovation in locking plate technology 
has improved our ability to treat fractures in 
osteoporotic bone and the development of “pre-
use of a “hybrid” locking plate for Complex metaphyseal 
fractures and nonunions about the humerus
contoured” or “anatomically 
correct” plate and screw designs 
has further advanced the ability 
to repair complex peri-articular 
fractures. 
The purpose of this 
retrospective study was to 
report on the use of a “hybrid” 
locking compression plate, 
the Synthes’ Hybrid LCP 
Metaphyseal Plate (Figure 1, 
Metaphyseal Plate, Synthes, 
Paoli, Pa.), that possesses 
different size locking holes at 
each end, for the treatment of 
complex proximal and distal 
humeral shaft fractures and 
nonunions by a single surgeon 
at a regional academic trauma 
center. Our hypothesis was 
that treatment of difficult 
metaphyseal humeral shaft 
fractures with this novel 
implant would have higher 
union rates and lower 
complication rates than those 
previously reported for similar 
injuries treated with conventional locked plating.
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hybrID loCkIng plaTe Continued on p. 16
fIgure 1: The Locked 
Metaphyseal plate utilized in 
this series.
fIgure 1:
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Our cohort consisted of 21 patients with 
humerus fractures who were treated over a two-
year period. Fourteen acute fractures and seven 
nonunions were identified in the study cohort. 
Our cohort consisted of six men and 15 women 
with a mean age of 49 years. All fractures were 
secured with a “hybrid” locking plate with a 
minimum of three 4.5mm screws on one side of 
the fracture and three 3.5mm screws on the other 
side (Figure 2). All patients were treated with a 
similar post-operative protocol for early range of 
shoulder and elbow motion. 
All patients in our cohort healed their frac-
ture or fracture nonunion demonstrating satis-
factory functional and radiographic results. The 
mean time to union following surgical interven-
tion was 4.5 months (Range 3-6). There were no 
implant-related complications and no small screw 
failures in this series. The metaphyseal locking 
plate seems to be ideal for situations in which it 
may be advantageous to place a greater number 
of screws within a small segment of bone, such as 
certain difficult fractures of the meta-diaphyseal 
humeral shaft. 
We concluded that the Hybrid LCP 
Metaphyseal Plate is a useful new implant that 
maximizes the advantages of locked compres-
sion plating in the treatment of certain difficult 
proximal and distal one-third fractures of the 
humerus that are not amenable to traditional 
plate and screw fixation. Meta-diaphyseal upper 
extremity long bones may serve as the most 
ideal location for this implant. Our retrospec-
tive analysis provides clinical verification of our 
hypothesis and indicates that treatment of this 
category of fractures is a promising new applica-
tion for the LCP Metaphyseal Plate.
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fIgure: 
2a. An AP trauma slot 
radiograph of a 32-year-old-
male who sustained a high 
energy distal humeral shaft 
fracture and was treated with a 
synthes LCP metaphyseal plate. 
 
2b. Post-operative AP radiograph 
at three months. 
 
2c. Post-operative lateral 
radiograph at three months.
Figure 2a
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Figure 2c
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The use of ultrasonography in 
trauma patients to assess the 
severity of intra-abdominal 
injury has become a frequent 
practice in surgery and emer-
gency departments. With the 
development of the Focused 
Assessment with Sonography 
for Trauma (FAST) examina-
tion in 1996, surgeons and 
emergency physicians in the 
U.S. began using ultrasound as 
a faster, noninvasive method to 
evaluate abdominal trauma.1 
The FAST exam is currently 
used extensively as a diagnostic tool for detecting 
fluid in the pericardium and peritoneum, indi-
cating serious injury (Figure 1).2
The current standard practice of ultrasound 
probe placement in the FAST exam for the 
right upper quadrant (RUQ) is to position the 
probe at the right midaxillary line between the 
10th and 12th ribs where liver, right kidney, 
diaphragm, and Morrison’s pouch should be 
identifiable in a coronal view. Similarly, the left 
upper quadrant (LUQ) probe position is at the 
left posterior axillary line between the 10th and 
12th ribs where spleen, left kidney, diaphragm, 
and splenorenal recess should be identifiable. 
According to available literature, flawed 
techniques and provider inexperience often have 
detrimental effects on imaging procedure.2
The application of a simpler, more straight-
forward method of performing the exam using 
easily identifiable landmarks may improve 
technique and enable less experienced physicians 
to complete the exam faster and more precisely. 
The purpose of this study was to establish two 
external anatomical landmarks, the hepatorenal 
point (H point) for the RUQ and the splenorenal 
point (S point) for the LUQ, to be used by novice 
operators to accurately complete the FAST exam 
in an emergency situation to generate instanta-
neous images of the target organs that are diag-
nostically adequate in patients. The H point is 
the intersection of the horizontal subxiphoid line 
and right midaxillary line; while the S point is 
The accuracy of a new external anatomical landmark on 
Visualization of Target organs during the fasT ultrasound exam
the intersection of horizontal subxiphoid line and 
left posterior axillary line. 
In the first phase of the study, providers 
(medical students and residents) were trained 
to perform the FAST exam using the proposed 
external landmarks. Medical students also com-
pleted a pre- and post-test questionnaire to eval-
uate their learning curve. In the second phase, 
providers performed the FAST exam in the 
emergency department under the supervision of 
credentialed attending physicians. Adjustments 
necessary to obtain an adequate view of target 
organs away from the initial landmark-predicted 
points were recorded. 
The site predicted by the landmark revealed 
the requisite organs at a rate of 82.4 percent at 
first attempt without need for further probe 
movement. There was a significant difference 
in precision rate between H and S points, at 
89.6 percent and 75.2 percent respectively 
(p < 0.01). In patients with BMI>30, providers 
had more challenges in visualizing the LUQ 
target organs by following the landmark, how-
ever, providers with more than 10 previous FAST 
experiences did not encounter such difficulties.
In conclusion, the study results demonstrate 
that the H and S landmarks serve as simple and 
fIgure 1: An ultrasound image of right upper quadrant showing 
a positive FAST result. Intraperitoneal fluid can be seen in Morrison’s 
Pouch.
anaTomICal lanDmark Continued on p. 18
Fusion • 200918
precise guides that can facilitate the teaching and 
performance of the FAST exam in the hands of 
inexperienced providers, including pre-clinical 
and clinical medical students.
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Bone volume is the result of a complex interac-
tion of genetic as well as environmental fac-
tors.1 For example, mechanical loading is an 
environmental factor that has been shown by 
experimental and observational data to affect 
bone size in a concept called “bone func-
tional adaptation.”2 Data from the Functional 
Polymorphisms Associated with Human Muscle 
Size and Strength (FMS) study,3 a multi-center 
study designed to evaluate the effects of genetic 
polymorphisms on bone geometry, fat volume, 
and muscle size and strength, offers the oppor-
tunity to investigate the relationship between 
bone volume and body weight, height, muscle 
size, and muscle strength (both isometric and 
isokinetic measurements), all potential sources 
of mechanical loading. The FMS study chose 
to investigate the humerus for several reasons, 
including its particular sensitivity for detecting 
genetic predisposition in bone and muscle health, 
as well as being a single bone and thus not sub-
ject to load sharing. It is also not weight-bearing 
and is therefore less affected by confounding 
factors such as fluctuations in weight or activity. 
However, the environment does play a substan-
tial role in humerus bone development. The 
objective of this study was to find correlative 
evidence that bone volume is affected by factors 
of mechanical loading and then investigate how 
sex modulates that influence in a population of 
young, healthy adult males and females.
In this study measures of bone volume, 
muscle strength and size of the dominant and 
non-dominant humerus were determined in 
sexual Dimorphism in humeral bone Volume 
in the young adult skeleton
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Caucasian subjects, male (n = 205) and female 
(n = 327). Subjects were between 18 and 40 
years of age (males mean age = 23.9 ± 5.7, 
females = 22.8 ± 5.2). Muscle size (volume), and 
bone volume were determined from Magnetic 
Resonance Images (MRI) of the distal 9.6 cm 
of the humeral diaphysis using semi-automated 
software from Rapidia®. Muscle strength was 
determined using both dynamic and isometric 
strength testing.
Both total bone volume and cortical bone 
volume was found to be highly correlated with 
weight in both males and females (Figure 1). 
Interestingly, the correlation was stronger 
between male bone size and weight (r2 = 0.27) 
than in female bones (r2 = 0.19). The differ-
ence between the sexes was even greater when 
comparing bone size to muscle strength, in both 
isometric and dynamic strength tests (Figure 2). 
Muscle volume is often considered representative 
of muscle strength in current research, however 
we found that while muscle volume did cor-
relate with muscle strength, it 
did so at a lower than expected 
level, r2 = 0.22, meaning only 
22 percent of muscle strength 
could be accounted for by its size. 
In addition, they correlated differ-
ently when compared to bone size, with muscle 
strength correlating more strongly than muscle 
volume with bone size. Again, these relation-
ships were found to be stronger in men than in 
women.
These results provide strong evidence that 
mechanical loading has a significant influence on 
bone volume. The young adult population of the 
FMS study gives a snapshot of the adult skeleton 
at the peak of bone growth in both males and 
sexual DImorphIsm Continued on p. 19
The young adult population of the FMS study gives a snapshot of the 
adult skeleton at the peak of bone growth in both males and females.
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females. It also provides evidence of the end-
result of the effects of mechanical loading factors 
including body weight and muscle strength, on 
the growth of the skeleton. Our study shows a 
clear difference within this population in the 
correlation between bone volume and the mea-
surements of body weight and muscle strength 
between males and females, possibly showing the 
effects of sex on bone growth. Since females tend 
to stop adding bone on the periosteal surfaces 
after puberty, the stronger correlations found 
in this study between bone size and mechanical 
stress in males clearly reflect the difference in 
growth patterns between genders.
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fIgure 1: Total Bone Volume vs. Weight in Females and Males.
fIgure 2: Dynamic Strength (one repetition max: 1-RM) vs. Total Bone Volume in Females and Males.
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Bone morphogenetic proteins (BMP), the only 
proteins known to have the osteoinductive 
capacity to generate new bone formation, 
were first isolated from bone 20 years ago.1 
BMPs are the focus of numerous studies 
seeking alternatives to the morbidity associated 
with autograft bone. In fact, studies have 
demonstrated that BMPs are a safe and effective 
alternative to allograft and autograft bone.1,2 Two 
such BMPs, BMP 2 and BMP 7, are typically 
used independently. However, recent in vitro and 
animal studies have investigated a synergistic 
effect when BMP 2 and BMP 7 are combined.3,4 
No clinical studies have investigated the use 
of combining BMP 2 and BMP 7 in lumbar 
fusions. Before addressing the efficacy of this 
combination in humans, it is important to 
establish the safety of combining these two 
materials in spinal surgery. This retrospective 
study aims to determine the prevalence of 
complications associated with combining BMP 2 
and BMP 7 in posterolateral lumbar fusions. 
The study followed a cohort of patients who 
received a combination of BMP 2 and BMP 7 in 
posterolateral lumbar fusions. Medical records 
were reviewed to determine the prevalence of 
post-operative complications such as infection, 
inflammation, hematoma, nerve damage, ectopic 
bone formation, and allergic reactions. Potential 
post-operative complications were compiled from 
the package inserts of BMP 2 and BMP 7 as 
reported by their manufacturers. Patients were 
followed for an average of 4.5 months.
Cross-referencing the medical records of 
patients who had received BMP 2 and BMP 7 
in posterolateral lumbar fusions revealed that 
29 of 30 patients (97 percent) showed no post-
operative complications associated with the 
combined BMP 2 and BMP 7 implant. One 
patient developed an infection at the surgical site 
that was cleared by oral antibiotics. There were 
no other cases of adverse events. 
The results from this study suggest that 
patients who receive both BMP 2 and BMP 7 
in a posterolateral lumbar fusion are not at any 
significant risk for complications arising directly 
from this combination. Future applications 
include studies seeking to measure the efficacy of 
this combination as well as to investigate other 
combinations that may be safely and effectively 
used to increase success rates in posterolateral 
lumbar fusions.
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Regardless of their occupation, socioeconomic 
status, or ethnicity, patients can often experience 
back pain at various times in their lives. Back 
pain can range from minor to severe excruciating 
pain. 
Unfortunately, there are a large number of 
patients whose pain is not alleviated by current 
physician interventions.
Dr. Norman Marcus, founder of The 
Norman Marcus Pain Institute (NMPI), chal-
lenges the well-accepted diagnostic and treat-
ment tools for addressing back pain. In focusing 
on a more accurate way to diagnose, Dr. Marcus 
believes that the patients not benefiting from 
current methods of pain relief 
are not incurable but are instead 
misdiagnosed. Many physicians 
do not realize that back pain 
is the result of muscular injury 
as opposed to neurovascular. 
Dr. Marcus enhanced the 
techniques to evaluate and treat 
muscle pain taught to him by 
Hans Kraus, MD, father of 
sports medicine and back pain 
specialist to President John F. Kennedy.
Painful muscles may develop hardened areas 
of taut muscle fiber, or “trigger points,” that are 
quiet at rest but if stimulated will produce pain. 
Various approaches have been suggested to treat 
these painful knots. The widely used method in 
determining the location of these painful nod-
ules is manual pressure via hand palpations. At 
these points, physicians tend to inject 5 percent 
Lidocaine (numbing agent), steroids, or just a dry 
needle stick, which would all serve to relax the 
muscle and possibly the nerve.
Manual pressure to identify trigger points 
does not adopt consistent reliability between 
different examiners. In addition, the palpations 
are being conducted upon resting muscles, which 
will not elicit the accurate response as it would in 
an active muscle. In order to combat the afore-
mentioned diagnostic difficulties, a Muscle Pain 
Detection Device (MPDD) has been formulated 
by Stevens Institute of Technology.1 The MPDD, 
a small device, uses electricity to harmlessly pro-
mote a muscle contraction on selected muscles 
thus altering its activity, which in turn allows the 
physician to identify which muscles are inducing 
the pain.
By utilizing the MPDD, physicians can have 
access to a more reliable and valid evaluation of 
muscle pain. To investigate these results, a ran-
domized controlled study of MPDD vs Manual 
Pressure was conducted. Forty patients with a 
three month history of back pain were divided 
blindly into two groups. Within each respective 
group, MPDD or Manual Pressure was utilized 
to identify the muscles creating the source of 
pain. All subjects were injected with 5 percent 
Lidocaine. Preceding the treatment along with 
one week and one month afterwards, the patients 
were given a physical exam and were asked to 
complete Oswestry and Visual Analogue Pain 
Scale questionnaires.
For both follow-up visitations, the MPDD 
group had an overall statistically significant 
improvement in mood, disability, and back pain 
(P < 0.004 - 0.001). At one month, there was a 
53.2 percent reduction in pain in the Manual 
Pressure group compared to the astounding 82.5 
percent (P < 0.001) pain relief in the MPDD 
group.
This study could revolutionize how back pain 
is perceived in the future. The MPDD should 
allow physicians to accurately diagnose the origin 
of the muscle pain and treat it more successfully. 
In appreciation to this investigation, back pain 
no longer has to possess an elusive diagnosis.
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In order to combat … diagnostic difficulties, a Muscle Pain Detection 
Device (MPDD) has been formulated. The MPDD, a small device, 
uses electricity to harmlessly promote a muscle contraction on selected 
muscles thus altering its activity, which in turn allows the physician to 
identify which muscles are inducing the pain.
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Preterm birth, defined as birth occurring earlier 
than 37 weeks gestational age (GA), is an increas-
ingly important public health concern in the 
United States as the percent of preterm births has 
risen to 12.6 percent of all births in 2005.1 Very 
preterm infants have significantly higher rates of 
cognitive impairment, sensory deficits, cerebral 
palsy, motor delay, and educational and social 
difficulties. Magnetic resonance imaging (MRI) 
examination for radiological abnormalities fre-
quent in preterm newborns — intraventricular 
hemorrhage, periventricular leukomalacia, and 
other white- and grey-matter abnormalities — is 
predictive of these deficits.2 
This study examined both preterm and 
term infants using a recently-employed imaging 
technique, functional connectivity MR, which 
examines spontaneous functional MRI (fMRI) 
signal fluctuations at rest. Functional connectivity 
has been extensively studied in adults and several 
regions have been identified as components of a 
“default mode network,” or DMN. The DMN 
is a group of neuroanatomical regions that are 
studying the Infant brain at rest: a Comparison of functional 
Connectivity between preterm and Term Infants
thought to function together and have been 
hypothesized to form the basis of cognition and 
self-referential thought, as indicated by synchro-
nous signal fluctuations identified by fMRI, PET, 
and EEG of resting individuals.3 This resting-state 
network has been found to differ in children, 
who possess less connections than adults, and was 
shown to deteriorate in aging and Alzheimer’s 
disease, thereby intimating its functional impor-
tance.4,5 Only one study has been conducted in 
infants, who were preterm newborns scanned at 
term-equivalent age; this study found that infants 
did not appear to have a DMN similar to adults.6
Our study addressed two questions: first, do 
infants possess any elements of the DMN seen in 
adults, and second, do preterm infants show dif-
ferent patterns of resting-state activity? To answer 
these questions, we utilized a seeds-based cor-
relational method, which looks at the fMRI time-
course within a selected region of the brain and 
compares it to the rest of the brain. If a disparate 
region has a similar pattern of signal over time, 
it is thought to be functionally connected to the 
region chosen. Results are depicted in Figure 1.
We identified one component of the adult 
DMN in both preterm and term infants, the 
anteroposterior connection between prefrontal 
cortex and posterior cingulate cortex. This 
finding differs from that of a previous study 
in infants and indicates that infants may have 
greater maturation in the DMN than previously 
thought.6 There was no apparent difference in 
resting state activity when comparing GA, but 
our study was limited to a set of 14 infants, 
four of which were term controls. Another 
important finding was that term infants 
showed greater interhemispheric correlations 
in functionally related regions such as the 
primary auditory, motor, and somatosensory 
cortices, whereas preterm infants had largely 
unilateral correlations. These findings have 
been demonstrated in EEG studies and suggest 
that, although interhemispheric anatomical 
connections exist much earlier, preterm 
infants may not have functional networks 
across hemispheres.7 Functional connectivity 
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fIgure 1: Representative examples of correlation maps generated by comparing seed regions (noted 
on left) to the individual subject’s fMRI at-rest. Seeds placed in the posterior cingulate cortex showed 
functional connectivity with the prefrontal cortex (arrows) in all groups and indicates elements of the DMN. 
Term infants had greater bilateral connectivity shown in the primary auditory cortex, primary motor cortex, 
and somatosensory cortex.
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may facilitate a greater understanding of the 
mechanisms by which the brain functions and 
how the disruption of this connectivity reflects 
deficits in cognition and functional impairment 
seen in preterm infants later in life.
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use of Trabecular metal Implants in anterior Cervical  
Discectomy and fusion: a Two-year retrospective study
Anterior cervical discectomy and fusion (ACDF) 
is a surgical procedure indicated in the treatment 
of compression injury in the cervical spine as 
a result of degenerative disc disease and herni-
ated discs. ACDF is designed to restore strength 
and stability to cervical vertebrae through the 
removal of damaged or diseased intervertebral 
discs and insertion of fusion-promoting bone 
grafts or synthetic interbody cage devices. 
Successful vertebral fusion results in restored 
intervertebral disc height, alleviation of spinal 
cord compression, maintenance of cervical lor-
dosis, and reduction in pain.1
Bone grafts, the implants of choice since the 
first ACDF was performed in 1953, have recently 
fallen out of favor due to complications such as 
graft expulsion, pseudarthrosis, and increased 
infection risk at the harvest site.2 In particular, 
autologous bone grafts are associated with 
increased donor-site morbidity.3 Allograft bone 
grafts, while eliminating donor-site complica-
tions, are associated with inferior fusion rates.2 
Synthetic interbody cages, such as trabecular 
metal implants, intend to eliminate the compli-
cations of bone grafts while providing the bene-
fits of intervertebral fusion. The use of trabecular 
metal implants has increased in the past decade 
due to its comparable characteristics to cancel-
lous bone.1 Trabecular metal is a highly porous 
composite of tantalum metal and vitreous carbon 
with inherent osteoconductive characteristics, 
such as high volumetric porosity, high frictional 
characteristics, excellent corrosion and erosion 
resistance, and a low modulus of elasticity. These 
features, which closely resemble cancellous bone, 
enhance the biocompatibility of the metal and 
promote rapid vascularization and tissue infiltra-
tion at the site of fusion.1
The primary objective of this study was to 
validate the use of trabecular metal implants in 
ACDF by measuring and comparing preopera-
tive and 24 months postoperative clinical and 
radiographic outcomes. The two-year mark was 
established to ensure spinal fusion could be suc-
cessfully determined and degeneration had not 
occurred at levels above or below the implant 
(a common problem with allograft implants). 
Inclusion criteria focused on male and female 
patients, ages 30 to 90 years old, who underwent 
either a single or multi-level ACDF with trabe-
cular metal implants during the study period 
from May 2004 to September 2008. The primary 
radiographic endpoint was evidence of fusion, 
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which was determined by percentage of lucency 
at each vertebral body, Cobb angle analysis, 
change in hardware position, spinous process 
motion in flexion/extension views, and percent 
lordosis change at each vertebral level. Initial 
radiographic analysis indicated all 30 patients had 
complete fusion at 24 months with no need for 
revision surgery. Primary clinical endpoints were 
obtained comparing preoperative and 24-month 
survey scores from the SF-36, the Neck Disability 
Index (NDI), and the Visual Analog Scale (VAS). 
The SF-36 measures functional social, physical, 
and mental health using a 100-point scale. 
Initial survey data indicated improvements of 
13.3 points and 13.2 points in the physical and 
mental component scores, respectively. The NDI, 
also using a 100-point scale, noted a 33.8-point 
reduction in neck disability. Additional analysis 
TrabeCular ImplanTs Continued from p. 23 is ongoing, but the positive fusion rates and 
improved clinical outcome data suggest the use 
of trabecular metal implants in ACDF should be 
explored further as a viable alternative to bone 
grafts. 
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Language dominance 
appears to be estab-
lished between four to 
seven years, but few 
functional Magnetic 
Resonance Imaging 
(fMRI) investigations 
focus on development 
of functional con-
nectivity of language 
networks in healthy 
children known to 
engage receptive (lis-
tening) and expressive 
(speaking) language 
regions. Functional connectivity is defined as the 
temporal correlation between spatially remote 
neurophysiological events.1 
We performed a cross-sectional functional 
connectivity analysis on fMRI data collected 
from an auditory description decision task from 
58 normally developing right handed children 
aged four to 12 years. The active condition 
requires a semantic decision based on a word 
definition while the control condition consists of 
reverse speech with tone identification. Regions 
of interest implicated in language-processing — 
the left inferior and middle frontal gyri (L-IFG 
and L-MFG), Wernicke’s area (L-WA), and right 
hemispheric homologues — were examined. 
Functional connectivity was measured between 
the left networks and their right homologues. 
functional Connectivity of language processing Development
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Paired regions were also compared across age 
groups, in relation to neuropsychological mea-
sures, and behavioral data. 
Significant connectivity by age group interac-
tion was found for L-IFG (p=0.03) and L-MFG 
(p=0.01). Post hoc analysis revealed age-related 
trends indicating 4–6 year-old children have 
less connectivity between L-IFG and L-WA 
than both 7–9 year-olds (p=0.08) and 10–12 
year-olds (p=0.11). There was also an age-related 
trend for 4–6 year-old children having more 
connectivity between L-MFG and R-MFG than 
the 10–12 year-olds (p=0.07). We found strong 
connectivity between homologous regions that 
persisted across age groups (IFG r=0.6437; MFG 
language proCessIng Continued on p. 25
fIgure 1: Group activation maps display areas of activation during the auditory description decision 
task. Regions of interest selected for study included the L-IFG (Broca’s area), L-MFG, L-MTG and L-STG 
(Wernicke’s area), and right sided homologues. Left-sided activation predominates, reflecting lateralization 
consistent with age-dependent development.
Fusion • 2009 25
r=0.7207; WA r=0.7152). The L-IFG—L-WA con-
nection positively correlated with expressive one 
word vocabulary (EOWV) (p=0.02) and trends 
were found for the WA and IFG homologues with 
other neuropsychological tests. There were no 
significant differences for behavioral measures.
The modest age-related findings reflect 
known anatomical and structural developments. 
Specifically, the greatest age-related changes 
occurred in the L-IFG and L-MFG, regions that 
demonstrate extended periods of maturation.2 
Additionally, the greater connectivity between 
left Broca’s area and left Wernicke’s area in the 
7–9 and 10–12 year-olds relative to the 4–6 
year-olds, reflects strengthening of that network, 
perhaps due to pruning of redundant or less 
utilized networks and consolidation.3 This reveals 
a mature arcuate fasciculus, the primary connec-
tion demonstrated in anatomical studies.4 The 
decrease in the L-MFG—R-MFG connection 
may represent the lateralization of attention and 
working memory functions that normally occurs 
with increases in age in right-handed individuals.5 
The protracted development of the frontal lobe 
may explain the significant age group interactions 
found in the L-IFG and L-MFG, while connec-
tions solidified outside this age range appear 
age-invariant.6 Connectivity correlations with 
performance on the EOWV test may reflect the 
observation that Broca’s area matures earlier than 
the more posterior language cortices7 leading 
to more conspicuous age-related changes in the 
expressive task within this pediatric population. 
Strong connections between homologous regions 
suggest a great deal of cross-talk, even after later-
ality has been established, which may represent 
left networks modulating the activity of their 
right homologues, task-dependent recruitment, 
or inter-hemisphere connections that serve as a 
reserve in the setting of injury.
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The relationship between health Care access and Disease 
activity and Damage in a multiethnic Cohort of systemic lupus 
erythematosus patients: The 1000 Canadian faces of lupus study 
Systemic lupus erythematosus (SLE) is a chronic 
autoimmune disease, whose prognosis can be 
influenced by environmental factors. The impor-
tance of access to care and its effects on SLE 
outcome is not well defined in the literature and 
measures of access have varied widely between 
studies. The first five years of the Lupus in 
Minorities: Nature Versus Nurture (LUMINA) 
longitudinal study indicated a perceived difficulty 
in obtaining health care to be more frequently 
reported in SLE patients who subsequently died 
(21.4 percent) compared to surviving patients 
(3.8 percent, p = 0.002).1 Treating early in disease 
onset and closer follow-up visits were hypoth-
esized to contribute to improved survival in 
SLE.2 Universal health care in Canada provides 
a unique setting for our investigation by mini-
mizing effects of income on access. Therefore 
this study was designed to determine whether 
care barriers are associated with increased disease 
activity and damage in a multi-center, multi-
ethnic Canadian SLE cohort. We also compared 
concordance between care barriers as reported by 
the patient and lupus specialist.
This was a retrospective study using data from 
14 Canadian centers with annual visits from 
patients with SLE. The patients’ prognosis was 
evaluated based on self-reported access to care. 
Access to care measures included availability 
of a family physician, financial barriers such as 
affording medication, and perceived difficulties 
in accessing rheumatology clinics and medica-
tions. Data including demographics, treatment, 
disease activity, and damage were analyzed. 
Damage was assessed using the SLICC ACR 
damage index developed by the American College 
of Rheumatology. Patient-reported access to 
care included availability of a family physician, 
financial barriers, and perceived difficulties in 
accessing rheumatology clinics and medications. 
We also compared patient’s assessment of care 
barriers they believed they faced, to what barriers 
their physicians thought might be impeding the 
patient’s access to care.
Our patient population extracted from the 
Canadian “1000 faces of Lupus” database con-
sisted of 654 patients. It is important to note that 
all patients had access to a lupus specialist yet 
many still faced barriers to care. Just over half 
(50.8 percent) of the patients perceived a care 
barrier despite universal health care in Canada; 
27.5 percent found cost of medication as a barrier 
to care, 19.6 percent reported waiting to see a 
rheumatologist as a barrier, 32 percent reported 
traveling to a rheumatologist’s office as a barrier, 
7.6 percent reported access to medication as a 
barrier and 8.6 percent reported cost of medical 
devices as a problem. 
Doctors and patients did not seem to identify 
similar care barriers (r = 0.09). Doctors cor-
rectly identified only half the patients who had 
access to medication problems (p = 0.003). Lack 
of access to medication and costs were signifi-
cantly associated with co-morbidity (p < 0.001, 
p = 0.04). Access to medication from the physi-
cian’s perspective was positively associated with 
SLE Disease Activity Index (p = 0.03) and cost of 
medication (p = 0.04). Physician perceived barrier 
of access to medication was associated with SLE 
activity (β = 1.14, p = 0.001).
We concluded that access to a lupus specialist 
does not necessarily imply adequate access to 
health care. Care barriers are important for 
lupus outcomes and are grossly underestimated 
by physicians. In health care it is essential for 
physicians to consider and recognize barriers to 
care when trying to improve the health status 
of their patients. More emphasis in physician 
training needs to be placed on recognizing and 
accommodating for these barriers in patient care. 
This study was a “best case scenario” where lupus 
patients were seeing a specialist and thus were 
entered into a lupus registry. This is unusual in 
the lupus population and especially in the United 
States where there are gaps in health insurance 
and thus the barriers to care are likely to be far 
greater.
reFerences:
1. alarCon gs, MCgWin g, BasTian hM, roseMan J, lisse J, Fessler 
BJ, eT al. Systemic Lupus Erythematosus in Three 
Ethnic Groups. VIII. Predictors of Early Mortality 
in the LUMINA Cohort. Arthritis Care and Research. 
2001; 45:191–202.
2. epsTein Wv, CurTis Jh. The Nature of U.S. Rheu-
matology Practice, 1977. Arthritis Rheum. 1981; 
24(9):1177–1187.
Fusion • 2009 27
Neglected tropical diseases (NTDs) impose a 
great burden on the global population, especially 
those living in poverty. Approximately one billion 
people are infected by one or more of the NTDs. 
Together, these diseases account for a greater 
portion of the total global Disability Adjusted 
Life Years (DALYs ) than tuberculosis or malaria 
combined. Of these diseases, human hookworms 
infect up to 576 million people worldwide. The 
majority of these infections are by the Necator 
americanus and Ancylosoma duodenale species 
and occur mostly in sub-Saharan Africa, China, 
Southeast Asia, and Latin America.
The impact of infection is greatest in children 
and pregnant women. Hookworm infection 
presents as severe anemia when the larvae embeds 
itself into the host intestinal wall, constantly 
causing cell injury and blood loss. There is 
stunted physical and cognitive development in 
children. Infected pregnant women have higher 
mortality and morbidity, as they are already 
anemic; the fetus is indirectly harmed.
Hookworm is easily treatable with oral 
medications such as Albendazole. However, high 
reinfection rates necessitates the development of 
an efficacious and cheap vaccine to be developed. 
Consequently, the Sabin Institute’s Human 
Hookworm Vaccine Initiative (HHVI), in collab-
oration with The George Washington University 
and Fundação Oswaldo Cruz, is conducting 
a hookworm vaccine clinical trial in the rural 
town of Americaninhas, Brazil. Americaninhas is 
located in a rural area approximately 500km from 
HHVI’s laboratory in Belo Horizonte. 
My primary role at the Americaninhas site 
was to shadow the HHVI physician as she rotated 
between various clinics during her monthly visit 
to the area. Rural residents do not have ready 
access to care, therefore, both HHVI and non-
study patients are seen. In contrast to how medi-
cine is practiced in the United States, the HHVI 
physician focuses solely on the history and the 
physical exam. Lacking modern diagnostic tools, 
we used only a stethoscope, sphygmomanometer, 
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and thermometer. I conducted the heart, lung, 
and abdominal exams. Many patients presented 
with conditions I will never see in the U.S. For 
instance, a family of eight was diagnosed with 
polyinfections of hookworm, ascaris, and schis-
tosoma. A young woman complaining of joint 
pains and fever was diagnosed with dengue fever 
using only a sphygmomanometer. Virtually every 
patient we treated was infected with hookworm, 
underscoring the need for a vaccine. 
The remainder of my summer was spent in 
the Belo Horizonte laboratory where I conducted 
Hemoquant and ELISA assays. Hemoquant 
quantifies hemoglobin in the feces of hookworm 
infected individuals. The primary goal of the 
project was to standardize the number of hook-
worm eggs to hemoglobin detected in feces by 
analyzing 1,000 fecal samples collected from 
patients living in 
Americaninhas and 
surrounding towns. 
Another project was 
to conduct ELISA 
assays and detect 
antibody response to 
a hookworm antigen. 
My experience 
in Brazil allowed me 
the opportunity to 
interact with unique 
patients and work 
on a vaccine clinical 
trial while learning 
about the Brazilian 
culture, language, 
and health care 
system.
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The human immunodeficiency virus (HIV) has 
defied a quarter century of attempts to create a 
safe and effective vaccine.1 More than 100 can-
didate vaccines have been evaluated in various 
stages of clinical trials; all of which have failed.2 
Recently, federal officials halted plans to advance 
a promising new HIV vaccine into a large clinical 
trial; the consensus being that researchers need 
to return to the bench before again proceeding 
to the bedside.3 This current state of affairs 
has significant implications for future invest-
ment and progress in HIV vaccine research and 
development.
In order to work, a protective HIV vaccine 
must teach the body’s immune system to recog-
nize specific viral proteins and to attack both the 
virus itself as well as virally-infected cells. Early 
efforts focused on the HIV envelope proteins, 
which represent the targets of neutralizing anti-
bodies produced by B-cells.4 These viral surface 
proteins are often highly variable, however, owing 
to the highly mutagenic nature of HIV. This 
means that a vaccine must invoke an exception-
ally broad immune response in order to be effec-
tive.5 In more recent efforts, as the importance of 
T-cell responses in the control of HIV infection 
became appreciated, researchers broadened their 
scope to evaluate vaccines that incorporated 
the more conserved internal proteins of HIV.4 
Although only antibodies can actually prevent 
infections by neutralizing the virus itself, a vac-
cine that aims to harness T-cells would theoreti-
cally keep the viral load in check and prevent the 
progression from HIV infection to AIDS.6 Over 
time, this strategy might even deplete the viral 
load due to incomplete replication of the virus 
within cells that are being killed. However, this 
approach is also inherently problematic because 
HIV selectively infects the CD4+ subset of 
T-cells, which are critical in initiating and main-
taining an adaptive immune response.
Most of the early efforts in HIV vaccine 
research and development were spearheaded 
by the pharmaceutical industry, but as the 
likelihood of a quick success decreased, private 
investment began to wane.7 At that time, HIV 
vaccine research began and continues to follow 
a somewhat atypical paradigm, with the public 
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sector supporting a greater share of all phases 
of research and development. Throughout this 
period, the public sector has been trying to 
employ mechanisms to engage industry while 
continuing to support investigator-driven research 
within academia. In 2004, three-quarters of all 
global expenditures for HIV vaccine research and 
development were estimated to have come from 
the U.S. government.4 Still, the National Institute 
of Allergy and Infectious Disease (NIAID) — 
the division of the National Institutes of Health 
(NIH) that undertakes most of the publicly 
supported HIV/AIDS research — devoted only 
28 percent of its HIV research funding to HIV 
vaccine research efforts.
Scientific uncertainty appears to be the most 
important reason for low investment in HIV 
vaccine research and development.7 There is an 
exceptionally poor understanding of the immune 
response needed for successful protection from 
HIV. Due to the inherent complexity of the situ-
ation with HIV, members of industry are largely 
unwilling to expose themselves to this degree of 
financial risk and potential for failure, especially 
when a substantial reward is unlikely. Vaccines, 
in general, have a more limited market and lower 
return on investment compared to therapeutic 
drugs. In this case, potential sales of all vaccines 
in the worldwide HIV space are estimated to 
represent only about $6.5 billion annually, or 2 
percent of the global pharmaceutical market, an 
amount that is roughly equivalent to the sales of 
one successful ulcer drug.8
In order to increase private investment in this 
space, there will probably have to be a combina-
tion of push strategies, which reduce the cost and 
scientific risk of investment, and pull strategies, 
which guarantee a viable market. While push 
strategies are particularly important during this 
early stage of vaccine development, pull strate-
gies will become important for poorer markets 
once the scientific problems have been solved. 
Unfortunately, the vicious cycle of HIV vaccine 
research and development will likely persist for 
quite some time, as scientific and fiscal barriers 
make industry reluctant to invest in the basic
hIV VaCCIne Continued on p. 29
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science research and clinical trials that are 
required to solve them.
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